• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病治疗的一个潜在靶点:外侧缰核损伤的影响

A potential target for the treatment of Parkinson's disease: effect of lateral habenula lesions.

作者信息

Han Bing, Jin Hui Juan, Song Mei Ying, Wang Tian, Zhao Hua

机构信息

Neuroscience Research Center, First Hospital of Jilin University, Changchun 130021, China; Department of Physiology, College of Basic Medical Sciences, Jilin University, Changchun 130021, China.

Department of Physiology, College of Basic Medical Sciences, Jilin University, Changchun 130021, China.

出版信息

Parkinsonism Relat Disord. 2014 Nov;20(11):1191-5. doi: 10.1016/j.parkreldis.2014.08.022. Epub 2014 Sep 1.

DOI:10.1016/j.parkreldis.2014.08.022
PMID:25219971
Abstract

OBJECTIVE

Parkinson's disease (PD) is a progressive neurodegenerative movement disorder that is caused predominantly by the degeneration of the nigrostriatal dopaminergic pathway. Lateral habenula (LHb) has efferent projections that terminate in the substantia nigra pars compacta (SNpc) and electrical stimulation of the LHb effectively suppresses the activity of dopamine-containing neurons in the SNpc. This study was aimed to investigate whether LHb lesions can ameliorate the syndromes of PD via affecting the activities of SNpc neurons in 6-hydroxydopamine (6-OHDA)-induced PD model rats.

METHODS

Concentrations of dopamine (DA) and its metabolites dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) in the striatum, which is the area projected by the SNpc dopaminergic neurons were assayed by high-performance liquid chromatography (HPLC) coupled with fluorescence detection. The immunohistochemical method was applied to detect the numbers of tyrosine hydroxylase (TH)-positive cells in the substantia nigra.

RESULTS

The results showed that LHb lesions induced a significant reduction in apomorphine-induced rotational behavior. The DA, DOPAC and HVA levels in the striatum of PD model rats were increased by the LHb lesions.

CONCLUSION

Therefore, we speculate that the LHb lesions induced a significant amelioration in motor disorders via increasing the DA levels in the striatum, which may lead to a potential therapeutic strategy for the treatment of PD.

摘要

目的

帕金森病(PD)是一种进行性神经退行性运动障碍,主要由黑质纹状体多巴胺能通路的退化引起。外侧缰核(LHb)有传出投射终止于黑质致密部(SNpc),电刺激LHb可有效抑制SNpc中含多巴胺神经元的活动。本研究旨在探讨LHb损伤是否能通过影响6-羟基多巴胺(6-OHDA)诱导的PD模型大鼠中SNpc神经元的活动来改善PD综合征。

方法

采用高效液相色谱(HPLC)结合荧光检测法测定纹状体中多巴胺(DA)及其代谢产物二羟基苯乙酸(DOPAC)和高香草酸(HVA)的浓度,纹状体是SNpc多巴胺能神经元投射的区域。应用免疫组织化学方法检测黑质中酪氨酸羟化酶(TH)阳性细胞的数量。

结果

结果显示,LHb损伤导致阿扑吗啡诱导的旋转行为显著减少。LHb损伤使PD模型大鼠纹状体中的DA、DOPAC和HVA水平升高。

结论

因此,我们推测LHb损伤通过增加纹状体中的DA水平显著改善了运动障碍,这可能为PD的治疗带来一种潜在的治疗策略。

相似文献

1
A potential target for the treatment of Parkinson's disease: effect of lateral habenula lesions.帕金森病治疗的一个潜在靶点:外侧缰核损伤的影响
Parkinsonism Relat Disord. 2014 Nov;20(11):1191-5. doi: 10.1016/j.parkreldis.2014.08.022. Epub 2014 Sep 1.
2
The subthalamic activity and striatal monoamine are modulated by subthalamic stimulation.丘脑底核刺激可调节丘脑底核活动和纹状体单胺。
Neuroscience. 2014 Feb 14;259:43-52. doi: 10.1016/j.neuroscience.2013.11.034. Epub 2013 Nov 27.
3
GABAA-receptor activation in the subthalamic nucleus compensates behavioral asymmetries in the hemiparkinsonian rat.丘脑底核 GABAA 受体的激活补偿了半帕金森大鼠的行为不对称性。
Behav Brain Res. 2013 Sep 1;252:58-67. doi: 10.1016/j.bbr.2013.05.044. Epub 2013 May 30.
4
The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease.抗氧化剂饮料有效微生物-X(EM-X)预处理可减轻帕金森病6-羟基多巴胺损伤大鼠模型中黑质纹状体多巴胺能神经元的损失。
J Pharm Pharmacol. 2004 May;56(5):649-54. doi: 10.1211/0022357023222.
5
Neuroprotective effect of hydroxysafflor yellow A on 6-hydroxydopamine-induced Parkinson's disease in rats.羟基红花黄色素 A 对大鼠 6-羟多巴胺诱导的帕金森病的神经保护作用。
Eur J Pharmacol. 2013 Aug 15;714(1-3):83-8. doi: 10.1016/j.ejphar.2013.06.011. Epub 2013 Jun 18.
6
Therapeutic effect of human amniotic epithelial cell transplantation into the lateral ventricle of hemiparkinsonian rats.人羊膜上皮细胞移植入半侧帕金森病大鼠侧脑室的治疗效果。
Chin Med J (Engl). 2009 Oct 20;122(20):2449-54.
7
Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's disease.作为帕金森病大鼠模型的内侧前脑束和纹状体6-羟基多巴胺损伤的组织学、行为学及神经化学评估
J Neurosci Methods. 2005 May 15;144(1):35-45. doi: 10.1016/j.jneumeth.2004.10.004. Epub 2004 Dec 8.
8
Increased melatonin may play dual roles in the striata of a 6-hydroxydopamine model of Parkinson's disease.褪黑素增加可能在帕金森病 6-羟多巴胺模型纹状体中起双重作用。
Life Sci. 2013 Mar 12;92(4-5):311-6. doi: 10.1016/j.lfs.2013.01.007. Epub 2013 Jan 16.
9
Ursolic acid attenuates oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in MPTP-induced Parkinsonian mouse model.熊果酸可减轻黑质纹状体组织中的氧化应激,并改善MPTP诱导的帕金森病小鼠模型的神经行为活动。
J Chem Neuroanat. 2016 Jan;71:41-9. doi: 10.1016/j.jchemneu.2015.12.002. Epub 2015 Dec 12.
10
Cyclosporin A attenuates the decrease in tyrosine hydroxylase immunoreactivity in nigrostriatal dopaminergic neurons and in striatal dopamine content in rats with intrastriatal injection of 6-hydroxydopamine.环孢菌素A可减轻纹状体内注射6-羟基多巴胺的大鼠黑质纹状体多巴胺能神经元中酪氨酸羟化酶免疫反应性及纹状体多巴胺含量的降低。
Exp Neurol. 1997 Aug;146(2):526-35. doi: 10.1006/exnr.1997.6575.

引用本文的文献

1
Quantitative and qualitative sex difference in habenula-induced inhibition of midbrain dopamine neurons in the rat.大鼠缰核诱导的中脑多巴胺能神经元抑制中的定量和定性性别差异。
Front Behav Neurosci. 2023 Nov 13;17:1289407. doi: 10.3389/fnbeh.2023.1289407. eCollection 2023.
2
Sleep Deprivation Influences Circadian Gene Expression in the Lateral Habenula.睡眠剥夺影响外侧缰核中的昼夜节律基因表达。
Behav Neurol. 2016;2016:7919534. doi: 10.1155/2016/7919534. Epub 2016 Jun 19.
3
Emerging preclinical pharmacological targets for Parkinson's disease.
帕金森病新出现的临床前药理学靶点。
Oncotarget. 2016 May 17;7(20):29835-63. doi: 10.18632/oncotarget.8104.